Duquesne University, Pfizer Inc., and National Institute for Pharmaceutical Technology and Education (NIPTE) have launched a research project called Timegated® Raman Spectroscopy to Improve Chemical Sensitivity for In-situ Bioreactor Monitoring.
The project is led by Dr. Carl Anderson, Associate Professor of Pharmaceutical Sciences and Associate Dean in Research and Graduate Programs. It focuses on applying Timegated® Raman spectroscopy to eliminate fluorescence from the measurements. As a participant in the project, Pfizer Inc. will provide the industrial perspective.
– By having a better limit of detection for both cellular metabolites and nutrients in the media, the current chemical state of a bioprocess can be more accurately understood. Therefore, we can control it much more effectively, Carl Anderson states.
McCrone Microscopes & Accessories, the U.S. distributor for Timegate Instruments, facilitated the collaboration by delivering Timegated® Raman spectrometer PicoRaman M3 to Duquesne University. The 18-month project, funded by National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), commenced in Pittsburgh, USA.